Ozempic (semaglutide) functions as a glucagon-like peptide-1 (GLP-1) receptor agonist that slows gastric emptying, increases satiety signals, and improves insulin sensitivity without direct stimulant effects
However, whether 200mg produces the same GLP-1 effects as the higher preclinical doses used in animal studies remains unconfirmed
Understanding these patterns helps protect you from this product and the dozens of similar ones flooding the market
If youre ready to take control of your weight loss with the help of GLP-1 treatments, contact us today at 805-983-1999 to schedule your consultation
We utilize a precision medicine obesity model, combining these powerful pharmaceutical tools with bespoke Peptide Therapy , NAD+ support , and personalized nutrition plans to ensure that patients are losing fat, preserving muscle mass , and fundamentally improving their biological age, not just their physical appearance. This integrative approach, leveraging these powerful agents alongside complementary protocols, is the defining standard of doctor-supervised medical weight loss in Connecticut
Clinical protocols typically begin tirzepatide at lower dosesoften 2.5 mg weekly for injectionsand escalate every 4 weeks until therapeutic effect is reached